Bio-link Australia Pty. Ltd.

Industry News

Please find below a list of selected recent news from the biotechnology industry.

The research collaboration and license agreement was originally initiated in October 2015. ..more
Mon, Oct 23, 2017
Source: BioSpace
ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. ..more
Mon, Oct 23, 2017
Source: BioSpace
The company is shuttering its GBT440 program to treat idiopathic pulmonary fibrosis (IPF). ..more
Mon, Oct 23, 2017
Source: BioSpace
DBV's share price crumbled over the weekend after its Phase III peanut allergy trial failed to show a statistically significant response against placebo. ..more
Mon, Oct 23, 2017
Source: BioSpace
TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. ..more
Mon, Oct 23, 2017
Source: BioSpace
The FDA based its decision on data from the COMBI-AD Phase III trial. ..more
Mon, Oct 23, 2017
Source: BioSpace
Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. ..more
Mon, Oct 23, 2017
Source: BioSpace
Two privately-held biotechs have merged to tackle recurrent C. difficile infections. ..more
Mon, Oct 23, 2017
Source: BioSpace
If J&J's going to keep rewarding investors, it's going to need these top drugs to continue racking up sales. ..more
Mon, Oct 23, 2017
Source: BioSpace
Immuno-oncology and gene therapy has been a hot field for the last few years, and the approval of the first CAR-T therapies has only set the kindling ablaze. ..more
Mon, Oct 23, 2017
Source: BioSpace